Global Antiviral Drugs Market Report 2022: A New Approach to Developing Antiviral Drugs Could Slow Future Viral Outbreaks and Save Lives - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 24, 2022--

The "Global Antiviral Drugs Market (2022-2027) by Drug Type, Therapeutics, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Antiviral Drugs Market is estimated to be USD 53.94 Bn in 2022 and is expected to reach USD 72.83 Bn by 2027, growing at a CAGR of 6.19%.

Market Dynamics

Drivers

• Growing Occurrence of Viral Diseases Such as HIV, Hepatitis, and Influenza
• Rising Government and Private Sector Expenditure in The Development of Antiviral Drugs
• Extensive Geriatric Population Coupled with Healthcare Awareness Among Consumers

Restraints

• Stringent Government Regualtions for Development of New Drugs

Opportunities

• Burgeoning Research and Development in the Production of Vaccines for Numerous Viral Infections and Diseases
• Extensive Formulations to Develop HIV Vaccines

Challenges

• Increasing Awareness of Preventative Treatments

   

   

Market Segmentations

The Global Antiviral Drugs Market is segmented based on Drug Type, Therapeutics, and Geography.

• By Drug Type, the market is classified into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others.
• By Therapeutics, the market is classified into HIV/Aids Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, and Pneumonia.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Antiviral Drugs Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Antiviral Drugs Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Antiviral Drugs Market, By Drug Type

7 Global Antiviral Drugs Market, By Therapeutics

8 Americas' Antiviral Drugs Market

9 Europe's Antiviral Drugs Market

10 Middle East and Africa's Antiviral Drugs Market

11 APAC's Antiviral Drugs Market

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

• Abacus Bioscience, Inc.
• Abbott Laboratories
• AbbVie, Inc.
• Aurobindo Pharma Ltd.
• Bristol-Myers Squibb Co.
• Chimerix, Inc.
• Cipla Ltd.
• Dr. Reddy's Laboratories
• ENYO Pharma SA
• F. Hoffmann-La Roche Ag
• Gilead Sciences, Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Mymetics Corp.
• Novo Nordisk A/S
• Pfizer Corp.
• Schering-Plough Corp.

For more information about this report visit https://www.researchandmarkets.com/r/oq504o

View source version on businesswire.com:https://www.businesswire.com/news/home/20221124005154/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.